Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of JNJ-16269110 on Hepatic Triglyceride Content in Obese Subjects
2007-006175-36Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of usistapide in obesity (3 arms), sponsored by Janssen Pharmaceutical. Started Dec 2007; status: completed.
02
Drugs
usistapide
03
Conditions
obesity
Beyond the preview
Go deeper on 2007-006175-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006175-36.